Associated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities
Downloads
Background: The COVID-19 pandemic caused by the SARS-CoV-2 virus has left infected patients with comorbidities in severe and deadly conditions. Hypertension is a non-communicable disease (NCD) and is one of the most common comorbidities observed in COVID-19 patients. Purpose: This study aims to understand the relationship between hypertension and the risk of death through COVID-19. Method: The study employed a systematic review of journals. Journals and articles related to hypertension and COVID-19 were collected and analyzed. The inclusion criteria was COVID-19 articles pertaining to hypertensive patients, and the exclusion criteria was articles that did not use English as well as those that did not display full text. Result: Hypertension is a multifactorial disease. The presence of hypertension is often not realized by the sufferer. A COVID-19 infection can worsen the condition of the person and can cause damage to vital organs. The use of antihypertensive drugs of the angiotensin-converting enzyme inhibitor (ACEI) and the angiotensin receptor blocker (ARB) groups can be continued to be administered to hypertensive patients. There should be no cause for concern for these patients to develop COVID-19 infections by taking these drugs. Conclusion: The risk of developing hypertension is that it can cause organ damage and lead to various complications. The SARS-CoV-2 infection in people with hypertension as a comorbidity, could worsen the condition of the individual until death occurs. Thus, hypertension management is necessary to properly minimize the severity.
American College of Cardiology. (2020). Coronavirus disease 2019 (COVID-19) provides potent reminder of the risk of infectious agents. Retrieved June 14, 2020, from https://www.acc.org/latest-in-cardiology/articles/2020/03/01/08/42/feature-coronavirus-disease-2019-covid-19-provides-potent-reminder-of-the-risk-of-infectious-agents
Arum, Y. T. G. (2019). Hipertensi pada penduduk usia produktif (15-64 tahun). HIGEIA (Journal of Public Health Research and Development), 3(3), 345–356.
Bjertness, M. B., Htet, A. S., Meyer, H. E., Htike, M. M. T., Zaw, K. K., Oo, W. M., ... Bjertness, E. (2016). Prevalence and determinants of hypertension in Myanmar - a nationwide cross-sectional study. BMC Public Health, 16(1), 1–10. https://doi.org/10.1186/s12889-016-3275-7
Bobeck, K. A., Holtzclaw, A. W., Brown, T. E., & Clark, P. A. (2020). Effective use of angiotensin II in coronavirus disease 19-associated mixed shock state: a case report. A&A Practice, 14(6), 1–3. https://doi.org/10.1213/XAA.0000000000001221
Bowman, T. S., Gaziano, J. M., Buring, J. E., & Sesso, H. D. (2007). A prospective study of cigarette smoking and risk of incident hypertension in women. Journal of the American College of Cardiology, 50(21), 2085–2092. https://doi.org/10.1016/j.jacc.2007.08.017
Caldeira, D., Alarcí£o, J., Vaz-Carneiro, A., & Costa, J. (2012). Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. BMJ (Online), 345, 1–20. https://doi.org/10.1136/bmj.e4260
Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., He, J., ... Zhong, N. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, 382(18), 1708–1720. https://doi.org/10.1056/nejmoa2002032
Gunawan, S. P., & Adriani, M. (2020). Obesity and stress level are associated with hypertension among adulthood in Klampis Ngasem, Surabaya. Media Gizi Indonesia, 15(2), 119–126.
Gupta, R., Ghosh, A., Kumar, A., & Misra, A. (2020). Clinical considerations for patients with diabetes in times of Covid-19 epidemic. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14, 211–212. https://doi.org/10.1016/j.dsx.2020.03.002
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ... Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395, 497–506.
Kusumawaty, J., Hidayat, N., & Ginanjar, E. (2016). Factors related events sex with hypertension in elderly work area health district Lakbok Ciamis. Mutiara Medika, 16(2), 46–51.
Liberale, L., Akhmedov, A., Vlachogiannis, N. I., Bonetti, N. R., Nageswaran, V., Miranda, M. X., ... Camici, G. G. (2020). Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic system. Cardiovascular Research, (Sep 15), cvaa268. https://doi.org/10.1093/cvr/cvaa268
Ministry of Health RI. (2020). Recent development situation (COVID-19). Jakarta. Ministry of Health RI. Retrieved October 4, 2020, from https://covid19.kemkes.go.id/download/Situasi_Terkini_050520.pdf
Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 109, 1–5. https://doi.org/10.1016/j.jaut.2020.102433
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020). Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine, 46(5), 846–848. https://doi.org/10.1007/s00134-020-05991-x
Supriyono, S. (2019). Analysis of factors relating to sistole blood pressure at participants in Puskesmas management train. Jurnal Inspirasi, 10(1), 32–48. https://doi.org/10.35880/inspirasi.v10i1.62
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., ... Schutte, A. E. (2020). 2020 International society of hypertension global hypertension practice guidelines. Hypertension, 75(6), 1334–1357. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
Wang, X., Pan, Z., & Cheng, Z. (2020). Association between 2019-nCoV transmission and N95 respirator use. Journal of Hospital Infection, 105(1), 104–105. https://doi.org/10.1016/j.jhin.2020.02.021
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., ... Song, Y. (2020). Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine, 180(7), 934–943.
Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., ... & Hao, P. (2020). Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences, 63(3), 457-460.
Yang, G., Tan, Z., Zhou, L., Yang, M., Peng, L., Liu, J., ... He, S. (2020). Effects of angiotensin II receptor blockers and ACE (angiotensin-converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with Covid-19 and hypertension: a single-center retrospective study. Hypertension, 76(1), 51–58.
Yuan, M., Yin, W., Tao, Z., Tan, W., & Hu, Y. (2020). Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS ONE, 15(3), 1–10. https://doi.org/10.1371/journal.pone.0230548
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine, 46(4), 586–590. https://doi.org/10.1007/s00134-020-05985-9
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., ... Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Zhou, P., Yang, X. Lou, Wang, X. G., Hu, B., Zhang, L., Zhang, W., ... Shi, Z. L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273.
- Every manuscript submitted to must observe the policy and terms set by the Jurnal Berkala Epidemiologi
- Publication rights to manuscript content published by the Jurnal Berkala Epidemiologi is owned by the journal with the consent and approval of the author(s) concerned. (download copyright agreement)
- Complete texts of electronically published manuscripts can be accessed free of charge if used for educational and research purposes according to copyright regulations.
JBE by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
